OBJECTIVE: To study the influence of types 2 and 3 confined placental mosaicism (CPM) on pregnancy outcome. METHOD: From 13 809 chorionic villus samplings (CVSs), karyotype after long-term cultured villi (LTC-villi) was systematically performed. Next, in case of suspicion of CPM, karyotype after short-term cultured villi (STC-villi) was established to define type 2 CPM (chromosomal abnormality limited to the mesenchymal core) or type 3 CPM (chromosomal abnormality found both in the cytotrophoblast and the mesenchymal core). Confirmatory amniocentesis was performed to exclude fetal mosaicism. Uniparental disomy (UPD) testing was carried out when the abnormal cell line involved chromosomes 5, 6, 7, 15 or 16. RESULTS: Fifty-seven CPM cases were observed (57/13 809 = 0.41%) and of these, 37 were type 2 and 20 were type 3 CPM. Incidence of preterm infants, neonatal hypotrophy and adverse pregnancy outcome were comparable between patients in whom type 2 CPM was demonstrated and the control population. In contrast, for the type 3 CPM the incidence of these factors was higher than for the control population. CONCLUSION: When a CPM is suspected, it appears essential to determine type, since type 2 has no effect on fetal development and type 3 is associated with preterm infants, low birth weight and adverse pregnancy outcome.
OBJECTIVE: To study the influence of types 2 and 3 confined placental mosaicism (CPM) on pregnancy outcome. METHOD: From 13 809 chorionic villus samplings (CVSs), karyotype after long-term cultured villi (LTC-villi) was systematically performed. Next, in case of suspicion of CPM, karyotype after short-term cultured villi (STC-villi) was established to define type 2 CPM (chromosomal abnormality limited to the mesenchymal core) or type 3 CPM (chromosomal abnormality found both in the cytotrophoblast and the mesenchymal core). Confirmatory amniocentesis was performed to exclude fetal mosaicism. Uniparental disomy (UPD) testing was carried out when the abnormal cell line involved chromosomes 5, 6, 7, 15 or 16. RESULTS: Fifty-seven CPM cases were observed (57/13 809 = 0.41%) and of these, 37 were type 2 and 20 were type 3 CPM. Incidence of preterm infants, neonatal hypotrophy and adverse pregnancy outcome were comparable between patients in whom type 2 CPM was demonstrated and the control population. In contrast, for the type 3 CPM the incidence of these factors was higher than for the control population. CONCLUSION: When a CPM is suspected, it appears essential to determine type, since type 2 has no effect on fetal development and type 3 is associated with preterm infants, low birth weight and adverse pregnancy outcome.
Authors: Diane Van Opstal; Merel C van Maarle; Klaske Lichtenbelt; Marjan M Weiss; Heleen Schuring-Blom; Shama L Bhola; Mariette J V Hoffer; Karin Huijsdens-van Amsterdam; Merryn V Macville; Angelique J A Kooper; Brigitte H W Faas; Lutgarde Govaerts; Gita M Tan-Sindhunata; Nicolette den Hollander; Ilse Feenstra; Robert-Jan H Galjaard; Dick Oepkes; Stijn Ghesquiere; Rutger W W Brouwer; Lean Beulen; Sander Bollen; Martin G Elferink; Roy Straver; Lidewij Henneman; Godelieve C Page-Christiaens; Erik A Sistermans Journal: Genet Med Date: 2017-09-28 Impact factor: 8.822
Authors: Roger V Lebo; Robert W Novak; Katherine Wolfe; Melonie Michelson; Haynes Robinson; Melissa S Mancuso Journal: J Transl Med Date: 2015-08-11 Impact factor: 5.531
Authors: Paula Jorge; Maria Manuela Mota-Freitas; Rosário Santos; Maria Luz Silva; Gabriela Soares; Ana Maria Fortuna Journal: J Clin Med Date: 2014-07-24 Impact factor: 4.241